Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 24% ± 8% | |
astrocyte | 5 studies | 28% ± 10% | |
glutamatergic neuron | 4 studies | 37% ± 21% | |
microglial cell | 4 studies | 21% ± 4% | |
epithelial cell | 4 studies | 24% ± 6% | |
oligodendrocyte | 4 studies | 19% ± 3% | |
macrophage | 4 studies | 22% ± 3% | |
neuron | 3 studies | 21% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 30% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8366.27 | 1445 / 1445 | 100% | 24.89 | 183 / 183 |
skin | 100% | 7514.63 | 1809 / 1809 | 100% | 23.18 | 471 / 472 |
prostate | 100% | 9148.08 | 245 / 245 | 100% | 25.53 | 500 / 502 |
breast | 100% | 6959.52 | 459 / 459 | 99% | 21.31 | 1110 / 1118 |
lung | 100% | 7705.05 | 578 / 578 | 99% | 18.38 | 1143 / 1155 |
pancreas | 100% | 3727.65 | 328 / 328 | 99% | 18.68 | 176 / 178 |
adrenal gland | 100% | 8736.99 | 258 / 258 | 99% | 24.70 | 227 / 230 |
thymus | 100% | 10553.18 | 653 / 653 | 99% | 23.29 | 596 / 605 |
kidney | 100% | 7174.94 | 89 / 89 | 98% | 19.02 | 886 / 901 |
intestine | 100% | 7391.06 | 966 / 966 | 98% | 13.52 | 517 / 527 |
stomach | 100% | 5686.93 | 359 / 359 | 98% | 15.35 | 279 / 286 |
bladder | 100% | 7630.90 | 21 / 21 | 97% | 16.10 | 491 / 504 |
uterus | 100% | 7996.74 | 170 / 170 | 97% | 17.84 | 446 / 459 |
brain | 98% | 4770.40 | 2581 / 2642 | 99% | 25.35 | 701 / 705 |
ovary | 100% | 7567.95 | 180 / 180 | 97% | 16.21 | 417 / 430 |
liver | 100% | 6030.50 | 226 / 226 | 92% | 13.34 | 373 / 406 |
adipose | 100% | 6321.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7489.97 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 19.52 | 80 / 80 |
spleen | 100% | 9807.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.71 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.95 | 1 / 1 |
muscle | 100% | 4200.60 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5279.87 | 917 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 3684.74 | 848 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 13.79 | 25 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0140958 | Biological process | target-directed miRNA degradation |
GO_2000627 | Biological process | positive regulation of miRNA catabolic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0031462 | Cellular component | Cul2-RING ubiquitin ligase complex |
GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | ZSWIM8 |
Protein name | Zinc finger SWIM-type containing 8 Zinc finger SWIM domain-containing protein 8 |
Synonyms | KIAA0913 |
Description | FUNCTION: Substrate recognition component of a SCF-like E3 ubiquitin-protein ligase complex that promotes target-directed microRNA degradation (TDMD), a process that mediates degradation of microRNAs (miRNAs) . The SCF-like E3 ubiquitin-protein ligase complex acts by catalyzing ubiquitination and subsequent degradation of AGO proteins (AGO1, AGO2, AGO3 and/or AGO4), thereby exposing miRNAs for degradation . Specifically recognizes and binds AGO proteins when they are engaged with a TDMD target . May also act as a regulator of axon guidance: specifically recognizes misfolded ROBO3 and promotes its ubiquitination and subsequent degradation . . |
Accessions | S4R3S6 ENST00000466354.1 S4R410 ENST00000604524.5 ENST00000433366.6 S4R3H3 ENST00000604729.6 ENST00000412198.5 A7E2V4 ENST00000603114.5 S4R3B3 ENST00000492395.5 ENST00000604754.1 ENST00000398706.6 [A7E2V4-4] ENST00000605216.5 [A7E2V4-1] H7BZ52 H7C453 S4R393 ENST00000603187.5 S4R3U7 H0YCW2 |